Solvias' announcement of opening a new biotech facility in Research Triangle Park, North Carolina, has sparked excitement and anticipation within the Raleigh-Durham area. The region, already renowned for its concentration of tech and biotech firms, is poised to add another jewel to its crown
In the evolving landscape of pharmaceuticals, the strategic partnership between Lantern Pharma and Oregon Therapeutics marks a significant milestone in the use of artificial intelligence (AI) for drug development. This collaboration centers on the advanced cancer drug candidate XCE853, an inhibitor
Magnetic Resonance Imaging (MRI) serves as a non-invasive diagnostic tool that plays a critical role in modern medicine. It utilizes a strong magnetic field and radiofrequency waves to generate detailed images of the internal structures of the body. MRI technology is invaluable across a range of
The scientific realm teeters on the brink of a paradigm shift, where artificial intelligence (AI) teases the frontiers of possibility, promising a revolution in how research is conducted. As laboratories increasingly implement AI systems, the rush to harness this avant-garde ally begets a crucial
The evolution of induced pluripotent stem cell (iPSC) culture is set to be revolutionized with the introduction of AMSBIO's StemFit™ Basic04 CT. This innovative cell culture medium, compliant with Good Manufacturing Practice (GMP) standards, is designed to significantly improve the cultivation
The pharmaceutical industry is undergoing a pivotal shift in its operational and strategic frameworks as cybersecurity emerges as a dominant concern. Company filings from the first quarter of 2024, analyzed by GlobalData, reveal a marked increase in the attention given to cybersecurity issues. This
Introduction The terrain of healthcare is undergoing a seismic shift, with analytics taking center stage in transforming patient care and operational efficiencies. The figures are compelling—a leap from USD 19.8 billion in 2020 to an eye-opening USD 118.55 billion by 2030. This metamorphosis s
Ireland's biopharmaceutical industry is on the verge of substantial expansion, with an expected increase of 21,000 jobs by 2027. The Expert Group on Future Skills Needs (EGFSN) has highlighted the essential role of the biopharma sector in bolstering the national economy. Despite the optimistic
The University of Delaware is making major strides in the biopharma sector by launching the new SABRE Center. Backed by $45 million in federal funding, including $10 million from the American Rescue Plan, this 90,000-square-foot hub is set to propel the university into a leader in biopharmaceutical
The fusion of synthetic biology (SynBio) with architecture is marking the beginning of a revolutionary shift towards eco-friendly building methods. At the forefront is Ginger Dosier with her pioneering company, Biomason; she represents the future of green construction. SynBio's integration
